2/14
02:42 am
crmd
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript [Seeking Alpha]
Low
Report
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript [Seeking Alpha]
2/12
08:52 am
crmd
CorMedix to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
CorMedix to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/12
08:30 am
crmd
CorMedix to Participate in Upcoming Investor Conferences
Low
Report
CorMedix to Participate in Upcoming Investor Conferences
2/12
06:37 am
crmd
CorMedix (NASDAQ:CRMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
CorMedix (NASDAQ:CRMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
2/11
03:28 pm
crmd
CorMedix Inc. (CRMD) Board Approves Multi-Year $75M Stock Buyback [Yahoo! Finance]
Low
Report
CorMedix Inc. (CRMD) Board Approves Multi-Year $75M Stock Buyback [Yahoo! Finance]
2/11
08:03 am
crmd
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
Medium
Report
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
2/2
09:17 am
crmd
CorMedix Therapeutics Announces Share Repurchase Program [Yahoo! Finance]
Medium
Report
CorMedix Therapeutics Announces Share Repurchase Program [Yahoo! Finance]
2/2
08:30 am
crmd
CorMedix Therapeutics Announces Share Repurchase Program
Low
Report
CorMedix Therapeutics Announces Share Repurchase Program
2/1
12:22 am
crmd
Assessing CorMedix (CRMD) Valuation After Recent Share Price Pressure And Long Term Gains [Yahoo! Finance]
Medium
Report
Assessing CorMedix (CRMD) Valuation After Recent Share Price Pressure And Long Term Gains [Yahoo! Finance]
1/31
07:03 pm
crmd
CorMedix Analyst Day To Clarify REZZAYO And DefenCath Phase III Path [Yahoo! Finance]
Medium
Report
CorMedix Analyst Day To Clarify REZZAYO And DefenCath Phase III Path [Yahoo! Finance]
1/31
08:12 am
crmd
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance [Yahoo! Finance]
Medium
Report
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance [Yahoo! Finance]
1/29
11:38 am
crmd
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 [Yahoo! Finance]
Low
Report
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 [Yahoo! Finance]
1/29
08:30 am
crmd
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
Medium
Report
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
1/23
08:04 am
crmd
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at HC Wainwright from $18.00 to $13.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at HC Wainwright from $18.00 to $13.00. They now have a "buy" rating on the stock.
1/21
08:02 am
crmd
CorMedix (NASDAQ:CRMD) was given a new $13.00 price target on by analysts at Royal Bank Of Canada.
Medium
Report
CorMedix (NASDAQ:CRMD) was given a new $13.00 price target on by analysts at Royal Bank Of Canada.
1/21
04:13 am
crmd
CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? [Yahoo! Finance]
Medium
Report
CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? [Yahoo! Finance]
1/11
03:57 am
crmd
CorMedix: The Post-TDAPA Hangover Arrived Early (Rating Downgrade) [Seeking Alpha]
Medium
Report
CorMedix: The Post-TDAPA Hangover Arrived Early (Rating Downgrade) [Seeking Alpha]
1/9
10:54 am
crmd
CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge [Seeking Alpha]
Medium
Report
CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge [Seeking Alpha]
1/9
08:30 am
crmd
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/9
08:02 am
crmd
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $15.00. They now have a "buy" rating on the stock.
1/9
04:31 am
crmd
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story [Yahoo! Finance]
Low
Report
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story [Yahoo! Finance]
1/8
04:38 pm
crmd
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes [Yahoo! Finance]
Low
Report
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes [Yahoo! Finance]
1/8
03:03 pm
crmd
CorMedix (NASDAQ:CRMD) was given a new $16.00 price target on by analysts at Truist Financial Corporation.
Low
Report
CorMedix (NASDAQ:CRMD) was given a new $16.00 price target on by analysts at Truist Financial Corporation.
1/8
02:48 pm
crmd
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
1/8
08:17 am
crmd
CorMedix Therapeutics Announces Leadership and Board Updates [Yahoo! Finance]
High
Report
CorMedix Therapeutics Announces Leadership and Board Updates [Yahoo! Finance]